Placebo B

DRUG6 trials

Sponsors

University of Utah, John D. Dingell VA Medical Center, University of Waterloo, Santa Barbara Cottage Hospital, Sciwind Biosciences APAC CO Pty. Ltd.

Conditions

Adenomatous Polyposis ColiAlcohol Withdrawal SyndromeDepressionDigestiveGastrointestinal HealthHealthyNonalcoholic SteatohepatitisObesity

Phase 1

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

CompletedNCT04389775

Sciwind Biosciences APAC CO Pty. Ltd.Nonalcoholic Steatohepatitis, Obesity, Type 2 Diabetes Mellitus

Start: 2020-03-29End: 2021-09-29Updated: 2021-10-28

Phase 2

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients

CompletedNCT01187901

University of UtahAdenomatous Polyposis Coli

Start: 2010-04-30End: 2014-07-31Updated: 2016-06-17

Phase 4

Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine

WithdrawnNCT03788889

Santa Barbara Cottage HospitalAlcohol Withdrawal Syndrome

Start: 2019-04-12End: 2019-04-12Updated: 2019-09-19

Unknown Phase

Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.

WithdrawnNCT02223299

John D. Dingell VA Medical CenterDepression

Start: 2015-11-30End: 2015-11-30Updated: 2020-02-21

Glutamate Supplementation in Young Men

CompletedNCT03425578

University of WaterlooHealthy

Start: 2018-03-19End: 2018-10-02Updated: 2019-06-12

Efficacy of Two Enzyme Cocktails in Healthy Adults

Not yet recruitingNCT06710392

The Archer-Daniels-Midland CompanyDigestive, Gastrointestinal Health

Start: 2024-12-15End: 2025-11-30Target: 100Updated: 2024-11-29

Related Papers

Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog.

2023-06-2427 citations

Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis

Gut2022-05-3020 citations

Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis

JAMA Oncology2018-02-0877 citations

Abstract LB-074: Regression of duodenal neoplasia in familial adenomatous polyposis patients using COX and EGFR inhibition: A randomized placebo-controlled trial

Cancer Research2016-07-15